SESN2 and neoplasm: Although SESN2 functions as expected in endometrial cell lines, SESN–mTORC1 signalling may be disrupted in the tumour microenvironment, as SESN2 levels do not correlate with reduced mTORC1 activity in endometrial tumours [79].